NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November 14, 2025 to its short form base shelf prospectus dated November 29, 2024. MARKHAM, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has completed its previously announced offering (the “Offerin ...

Trump Media and Technology Group (TMTG), the parent firm of his Truth social media outlet, is merging with TAE Technologies, a nuclear fusion power company, in a deal valued at $6 billion. The unusual pairing is expected to close in the middle of next year and will give shareholders of both companies equal ownership of the combined entity. The merged company will result in what the companies are calling “one of the world’s first publicly traded fusion companies.” As part of the transaction, TMTG has agr ...

Morning Minute is a daily newsletter written by Tyler Warner. The analysis and opinions expressed are his own and do not necessarily reflect those of Decrypt. Subscribe to the Morning Minute on Substack. GM! Today’s top news: Crypto majors mixed with BTC leading at $87,400 Coinbase rolled out several new products including prediction markets, stocks, equity perps, DEX and more DTCC to issue tokenized securites on Canton Network Citadel and other banks plan to spend $100M to counter crypto spend in ...

for some insights and stats on the markets. Let's bring in Ryan Dietrich, chief market strategist at Carson Group. Ryan, good to see you. >> Good to be here.Always enjoy your fine cities. >> Yes. And uh glad to have you uh along with the masses that that come this time of year.>> It's crowded out there. >> Um so if we were to get to a new high in the S&P by the end of the year, we're talking about eight and a half trading sessions until we're done. It's like a 3% move.So I mean, what gives you confidence if ...

Group 1 - Shares in the president's media company increased significantly in premarket trading following the announcement of a partnership with TAE Technologies [1] - The partnership is structured as an all-stock deal, indicating a strategic alignment between the two companies [1] - This development suggests potential growth opportunities for the media company as it expands its collaboration with TAE Technologies [1]

If you own Intel shares or have retirement funds invested in the tech sector, the company's recent leadership turmoil could significantly affect your portfolio. The crisis at Intel isn't just about internal governance—it's intertwined with political interference, international tensions, and market instability.Intel Corporation has experienced a dramatic decline in its stock value in 2024, losing over 60% of its market capitalisation. Now, fresh scrutiny over its chief executive's personal investments and po ...

分组1 - Birkenstock reported quarterly earnings of $0.6 per share, exceeding the Zacks Consensus Estimate of $0.4 per share, and showing an increase from $0.32 per share a year ago, representing an earnings surprise of +50.00% [1] - The company achieved revenues of $615.25 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.41%, and up from $500.9 million year-over-year [2] - Birkenstock has outperformed consensus EPS estimates in all four of the last quarters and has topped revenue estimates two times in the same period [2] 分组2 - The stock has underperformed the market, losing about 18.1% since the beginning of the year, while the S&P 500 gained 14.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $463.6 million, and for the current fiscal year, it is $2.30 on revenues of $2.75 billion [7] - The Shoes and Retail Apparel industry, to which Birkenstock belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Group 1 - Xponential Fitness (XPOF) has secured a new loan agreement with improved conditions, which alleviates short-term refinancing risks and significantly lowers interest expenses [1] - A portion of the new debt will be allocated to buy out preferred shares, thereby eliminating associated financial obligations [1] Group 2 - The financial analyst specializes in B2C software and internet content industries, focusing on industry trends, opportunities, and challenges [1] - The investment process involves analyzing earnings reports, earnings calls, and understanding the company's future outlook, industry position, competitive advantages, and potential threats [1] - The analyst builds DCF and relative valuation models to assess if a company is undervalued, typically reviewing over 10 companies to find one that meets this criterion [1]

Core Insights - Sangamo Therapeutics has initiated a rolling submission of a Biological License Application (BLA) to the FDA for isaralgagene civaparvovec, a gene therapy for Fabry disease, with expectations to complete the submission by Q2 2026 [1][4] Group 1: Study Results and Regulatory Pathway - The STAAR study demonstrated a positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52 weeks across all dosed patients, which the FDA has agreed will serve as an endpoint for accelerated approval [1][3] - Isaralgagene civaparvovec has shown a favorable safety and tolerability profile, indicating its potential as a one-time, durable treatment for Fabry disease [1][3] - The rolling submission process allows for completed modules of the BLA to be reviewed by the FDA on an ongoing basis, rather than waiting for the entire application to be submitted [2] Group 2: Designations and Company Background - Isaralgagene civaparvovec has received multiple designations from regulatory bodies, including Orphan Drug, Fast Track, and RMAT from the FDA, as well as Orphan Medicinal Product designation from the European Medicines Agency [4] - Sangamo Therapeutics is focused on genomic medicine, aiming to develop treatments for serious neurological diseases and has a pipeline that includes partnered programs and opportunities for investment [7]

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly†), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, California. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, Executive Vice President & Chief Financial Officer; and. ...